본문 바로가기
KERD
논문KCI 등재

Cholinesterase inhibitory activities of neuroprotective fraction derived from red alga Gracilaria manilaensis

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류수산학

초록

Anti-cholinesterase (ChE)s are commonly prescribed as the symptomatic treatment of Alzheimer’s disease. They are applied to prevent the breakdown of neurotransmitter acetylcholine (ACh) that bind to muscarinic and nicotinic receptors in the synaptic cleft. Seaweeds are one of the richest sources of bioactive compounds for both nutraceuticals and pharmacognosy applications. This study aimed to determine the anti-ChEs activity of Gracilaria manilaensis, one of the red seaweeds notables for its economic importance as food and raw materials for agar production. Methanol extracts (GMM) of G. manilaensis were prepared through maceration, and further purified with column chromatography into a semi-pure fraction. Ellman assay was carried out to determine the anti-acetylcholinesterase (AChE) and anti-butyrylcholinesterase (BuChE) activities of extracts and fractions. Lineweaver- Burk plot analysis was carried out to determine the inhibition kinetic of potent extract and fraction. Major compound(s) from the most potent fraction was determined by liquid chromatography-mass spectrometry (LCMS). GMM and fraction G (GMMG) showed significant inhibitory activity AChE with EC50 of 2.6 mg/mL and 2.3 mg/mL respectively. GMM and GMMG exhibit mixed-inhibition and uncompetitive inhibition respectively against AChE. GMMG possesses neuroprotective compounds such as cynerine A, graveolinine, militarinone A, eplerenone and curumenol. These findings showed a promising insight of G. manilaensis to be served as a nutraceutical for neuronal health care in the future.

Abstract

Anti-cholinesterase (ChE)s are commonly prescribed as the symptomatic treatment of Alzheimer’s disease. They are applied to prevent the breakdown of neurotransmitter acetylcholine (ACh) that bind to muscarinic and nicotinic receptors in the synaptic cleft. Seaweeds are one of the richest sources of bioactive compounds for both nutraceuticals and pharmacognosy applications. This study aimed to determine the anti-ChEs activity of Gracilaria manilaensis, one of the red seaweeds notables for its economic importance as food and raw materials for agar production. Methanol extracts (GMM) of G. manilaensis were prepared through maceration, and further purified with column chromatography into a semi-pure fraction. Ellman assay was carried out to determine the anti-acetylcholinesterase (AChE) and anti-butyrylcholinesterase (BuChE) activities of extracts and fractions. Lineweaver- Burk plot analysis was carried out to determine the inhibition kinetic of potent extract and fraction. Major compound(s) from the most potent fraction was determined by liquid chromatography-mass spectrometry (LCMS). GMM and fraction G (GMMG) showed significant inhibitory activity AChE with EC50 of 2.6 mg/mL and 2.3 mg/mL respectively. GMM and GMMG exhibit mixed-inhibition and uncompetitive inhibition respectively against AChE. GMMG possesses neuroprotective compounds such as cynerine A, graveolinine, militarinone A, eplerenone and curumenol. These findings showed a promising insight of G. manilaensis to be served as a nutraceutical for neuronal health care in the future.

참고문헌 (67)

  1. Alzheimer’s Association, "2021 Alzheimer’s disease facts and figures", J Alzheimer Dement, 17, pp.327~406 (2021)
  2. An ZY, "Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities", Eur J Med Chem, 45, pp.3895~3903 (2010)
  3. Andriani Y, "Biological activities of isolated compounds from three edible Malaysian red seaweeds, Gracilaria changii, G. manilaensis and Gracilaria sp", Nat Prod Commun, 11, pp.1117~1120 (2016)
  4. Api AM, "RIFM fragrance ingredient safety assessment, (2E, 6Z)-nona-2, 6-dien-1-ol, CAS registry number 28069-72-9", Food Chem Toxicol, 84, pp.S57~S65 (2015)
  5. Api AM, "RIFM fragrance ingredient safety assessment, (E, Z)-2, 6-nonadien-1-ol acetate, CAS registry number 68555-65-7", Food Chem Toxicol, 127, pp.S216~S223 (2019)
  6. Bagheri E, "Ethanolic extract of Brucea javanica inhibit proliferation of HCT-116 colon cancer cells via caspase activation", RSC Advances, 8, pp.681~689 (2018)
  7. Bayorh M, "Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase", J Renin Angiotensin Aldosterone Syst, 13, pp.353~359 (2012)
  8. Cao CY, "Sarcodonin G derivatives exhibit distinctive effects on neurite outgrowth by modulating NGF signaling in PC12 cells", ACS Chem Neurosci, 9, pp.1607~1615 (2018)
  9. Chen B, "Eplerenone modulates interleukin-33", sST2 signaling and IL-1β in left ventricular systolic dysfunction after acute myocardial infarction, 2018, pp.38, 137~144
  10. Chen H, "Eplerenone-mediated aldosterone blockade prevents renal fibrosis by reducing renal inflammation, interstitial cell proliferation and oxidative stress", Kidney Blood Press Res, 37, pp.557~566 (2013)
  11. Cheng Y, "(+)-N-Deoxymilitarinone A, a neuritogenic pyridone alkaloid from the insect pathogenic fungus Paecilomyces farinosus", J Nat Prod, 69, pp.436~438 (2006)
  12. Colović MB, "Acetylcholinesterase inhibitors : pharmacology and toxicology", Curr Neuropharmacol, 11, pp.315~335 (2013)
  13. Dong F, "Mineralocorticoid receptor blocker eplerenone reduces pain behaviors in vivo and decreases excitability in small-diameter sensory neurons from local inflamed dorsal root ganglia in vitro", Anesthesiology, 117, pp.1102~1112 (2012)
  14. Endo A, "ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium", J Antibiot, 29, pp.1346~1348 (1976)
  15. Flath RA, "Volatile components of Acacia sp. blossoms", J Agric Food Chem, 31, pp.1167~1170 (1983)
  16. Gutiérrez M, "Isoxazoles : synthesis, evaluation and bioinformatic design as acetylcholinesterase inhibitors", J Pharm Pharmacol, 65, pp.1796~1804 (2013)
  17. Ferreira-Vieira TH, "Alzheimer’s disease : targeting the cholinergic system", Curr Neuropharmacol, 14, pp.101~115 (2016)
  18. Hamdi OAA, "Neuroprotective and antioxidant constituents from Curcuma zedoaria rhizomes", Rec Nat Prod, 9, pp.349~355 (2015)
  19. Hsiao JW, "A new sesquiterpenoid and bioactive constituents of Curcuma zedoaria", Chem Nat Compd, 56, pp.1076~1080 (2020)
  20. Hung SY, "Drug candidates in clinical trials for Alzheimer’s disease", J Biomed Sci, 24, pp.47~ (2017)
  21. Jońca J, "New insights into butyrylcholinesterase activity assay : serum dilution factor as a crucial parameter", PLOS ONE, 10, pp.e0139480~ (2015)
  22. Kandiah N, "Rivastigmine : the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia", Clin Interv Aging, 12, pp.697~707 (2017)
  23. Kannan RRR, "Acetylcholinesterase inhibitory activity of phlorotannins isolated from the brown alga, Ecklonia maxima(Osbeck)Papenfuss", Food Res Int, 54, pp.1250~1254 (2013)
  24. Kemp TR, "Identification of some volatile compounds from cucumber", J Agric Food Chem, 22, pp.717~718 (1974)
  25. Kihara T, "Alzheimer’s disease and acetylcholine receptors", Acta Neurobiol Exp, 64, pp.99~105 (2004)
  26. Küenzi P, "Promotion of cell death or neurite outgrowth in PC-12 and N2a cells by the fungal alkaloid militarinone A depends on basal expression of p53", Apoptosis, 13, pp.364~376 (2008)
  27. Łabuzek K, "Eplerenone mimics features of the alternative activation in macrophages obtained from patients with heart failure and healthy volunteers", Eur J Pharmacol, 726, pp.96~108 (2014)
  28. Lo JY, "Curcumenol isolated from Curcuma zedoaria suppresses Akt-mediated NF-κB activation and p38 MAPK signaling pathway in LPS-stimulated BV-2 microglial cells", Food Funct, 6, pp.3550~3559 (2015)
  29. Loizzo MR, "Natural products targeting clinically relevant enzymes", pp.135~153 (2017), Wiley-VCH
  30. Lombardo S, "Role of the nicotinic acetylcholine receptor in Alzheimer’s disease pathology and treatment", Neuropharmacology, 96, pp.255~262 (2015)
  31. Luo W, "Synthesis, in vitro and in vivo biological evaluation of novel graveolinine derivatives as potential anti-Alzheimer’s agents", Bioorg Med Chem, 28, pp.115190~ (2020)
  32. Machado LP, "Evaluation of acetylcholinesterase inhibitory activity of Brazilian red macroalgae organic extracts", Rev Bras Farmacogn, 25, pp.657~662 (2015)
  33. Marcotullio MC, "Phytochemical analysis and antiradical properties of Sarcodon imbricatus(L. : Fr)Karsten", Nat Prod Commun, 3, pp.1907~1910 (2008)
  34. Marcotullio MC, "Neurite outgrowth activity of cyathane diterpenes from Sarcodon cyrneus, cyrneines A and B", Planta Med, 72, pp.819~823 (2006)
  35. McGinty D, "Fragrance material review on(2E, 6Z)-nona-2, 6-dien-1-ol", Food Chem Toxicol, 48, pp.S91~2 (2010)
  36. Mielke MM, "Effects of food and drug administration-approved medications for Alzheimer’s disease on clinical progression", Alzheimers Dement, 8, pp.180~187 (2012)
  37. Ng PK, "Genetic and morphological analyses of Gracilaria firma and G. changii(Gracilariaceae, Rhodophyta), the commercially important agarophytes in western Pacific", PLOS ONE, 12, pp.1~21 (2017)
  38. Nitthithanasilp S, "Antimicrobial activity of cyathane derivatives from Cyathus subglobisporus BCC44381", Tetrahedron, 74, pp.6907~6916 (2018)
  39. Obara Y, "A novel cyathane diterpene, cyrneine A, induces neurite outgrowth in a Rac1-dependent mechanism in PC12 cells", Life Sci, 80, pp.1669~1677 (2007)
  40. Okubo H, "Association between dietary patterns and cognitive function among 70-year-old Japanese elderly : a cross-sectional analysis of the SONIC study", Nutr J, 16, pp.56~ (2017)
  41. Pang JR, "Neuritogenic and in vitro antioxidant activities of Malaysian Gracilaria manilaensis Yamamoto & Trono", J Appl Phycol, 30, pp.3253~3260 (2018)
  42. Pangestuti R, "Neuroprotective effects of marine algae", Mar Drugs, 9, pp.803~818 (2011)
  43. Phang SM, "The seaweed resources of Malaysia", Bot Mar, 62, pp.265~273 (2019)
  44. Pintatum A, "In vitro anti-inflammatory, anti-oxidant, and cytotoxic activities of four Curcuma species and the isolation of compounds from Curcuma aromatica rhizome", Biomolecules, 10, pp.799~ (2020)
  45. Reid T, "Characterization of anti-Salmonella typhi compounds from medicinal mushroom extracts from Zimbabwe", Int J Med Mushrooms, 21, pp.713~724 (2019)
  46. Riese U, "Militarinone A induces differentiation in PC12 cells via MAP and Akt kinase signal transduction pathways", FEBS Lett, 577, pp.455~459 (2004)
  47. Ruangritchankul S, "Adverse drug reactions of acetylcholinesterase inhibitors in older people living with dementia : a comprehensive literature review", Ther Clin Risk Manag, 17, pp.927~949 (2021)
  48. Schmidt K, "Militarinone A, a neurotrophic pyridone alkaloid from Paecilomyces militaris", Org Lett, 4, pp.197~199 (2002)
  49. Schröder P, "Neuritogenic militarinone-inspired 4-hydroxypyridones target the stress pathway kinase MAP4K4", Angew Chem Int Ed Engl, 54, pp.12398~12403 (2015)
  50. Mahinda Senevirathne, "Enzymatic Extracts from Edible Red Algae, Porphyra tenera, and Their Antioxidant, Anti-acetylcholinesterase, and Anti-inflammatory Activities", Food Science and Biotechnology, 19(6), pp.1551~1557 (2010), 한국식품과학회
  51. Silverthorn DU, "Human Physiology: An Integrated Approach", pp.277~284 (2016), Pearson
  52. Suganthy N, "Neuroprotective effect of seaweeds inhabiting South Indian coastal area(Hare Island, Gulf of Mannar Marine Biosphere Reserve) : cholinesterase inhibitory effect of Hypnea valentiae and Ulva reticulata", Neurosci Lett, 468, pp.216~219 (2010)
  53. Suzuki J, "Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation", Arterioscler Thromb Vasc Biol, 26, pp.917~921 (2006)
  54. Syad AN, "Neuroprotective effect of the marine macroalga Gelidiella acerosa : identification of active compounds through bioactivity-guided fractionation", Pharm Biol, 54, pp.2073~2081 (2016)
  55. Syad AN, "Assessment of anticholinesterase activity of Gelidiella acerosa : implications for its therapeutic potential against Alzheimer’s disease", Evid Based Complement Alternat Med, 2012, pp.497242~ (2012)
  56. Tanaka K, "Prediction of cyclooxygenase inhibitory activity of Curcuma rhizome from chromatograms by multivariate analysis", Chem Pharm Bull, 56, pp.936~940 (2008)
  57. Tsuno N, "Donepezil in the treatment of patients with Alzheimer’s disease", Expert Rev Neurother, 9, pp.591~598 (2009)
  58. Vecchiola A, "Eplerenone implantation improved adipose dysfunction averting RAAS activation and cell division", Front Endocrinol, 11, pp.223~ (2020)
  59. Wada T, "Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance", J Endocrinol, 235, pp.179~191 (2017)
  60. Wang B, "Production of bioactive cyathane diterpenes by a bird’s nest fungus Cyathus gansuensis growing on cooked rice", Food Chem, 152, pp.169~176 (2014)
  61. Wang X, "Effects of eplerenone on cerebral aldosterone levels and brain lesions in spontaneously hypertensive rats", Clin Exp Hypertens, 42, pp.531~538 (2020)
  62. "Dementia" (2021)[URL]
  63. Wu TS, "Cytotoxic and antiplatelet aggregation principles of Ruta graveolens", J Chin Chem Soc, 50, pp.171~178 (2003)
  64. Xiao J, "Anti-inflammatory effects of eplerenone on viral myocarditis", Eur J Heart Fail, 11, pp.349~353 (2009)
  65. Yoon NY, "Acetyl-and butyrylcholinesterase inhibitory activities of sterols and phlorotannins from Ecklonia stolonifera", Fish Sci, 74, pp.200~207 (2008)
  66. Yoon NY, "Phlorotannins from Ishige okamurae and their acetyl-and butyrylcholinesterase inhibitory effects", J Funct Foods, 1, pp.331~335 (2009)
  67. Yow YY, "Assessing the use of mitochondrial cox1 gene and cox2-3 spacer for genetic diversity study of Malaysian Gracilaria changii(Gracilariaceae, Rhodophyta)from Peninsular Malaysia", J Appl Phycol, 25, pp.831~838 (2013)

관련 논문AI추천

이 간행물의 다른 논문 (4건)